A phase lb study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors

被引：1
|
作者：
Weekes, Colin
Lockhart, A. Craig
Lenz, Heinz-Josef
Lee, James J.
Cleton, Adriaan
Huang, Funan
Sturm, Isrid
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-CT148
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT148
引用
收藏
页数：4
相关论文
共 50 条
  • [41] A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors
    Josephia R. Muindi
    Candace S. Johnson
    Donald L. Trump
    Renee Christy
    Kristie L. Engler
    Marwan G. Fakih
    Cancer Chemotherapy and Pharmacology, 2009, 65 : 33 - 40
  • [42] Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors
    Toshihiko Doi
    Atsushi Ohtsu
    Makoto Tahara
    Tomohide Tamura
    Kuniaki Shirao
    Yasuhide Yamada
    Satoru Otani
    Bing-Bing Yang
    Masayuki Ohkura
    Tomoko Ohtsu
    International Journal of Clinical Oncology, 2009, 14 : 307 - 314
  • [43] Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors
    Doi, Toshihiko
    Ohtsu, Atsushi
    Tahara, Makoto
    Tamura, Tomohide
    Shirao, Kuniaki
    Yamada, Yasuhide
    Otani, Satoru
    Yang, Bing-Bing
    Ohkura, Masayuki
    Ohtsu, Tomoko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (04) : 307 - 314
  • [44] Phase I dose-escalation trial evaluating the safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors
    Awada, A.
    Gil, T.
    Whenham, N.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Loembe, B.
    Piccart, M.
    Hendlisz, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 39 - 39
  • [45] A phase I study of safety and pharmacokinetics of NanoBB-1-Dox in patients with advanced solid tumors.
    Filon, Olga
    Krivorotko, Petr
    Kobyakov, Grigory
    Razjivina, Viktoria
    Maximenko, Olga
    Gelperina, Svetlana
    Kreuter, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] A phase I study of the safety, tolerability, and pharmacokinetics of intravenous XMT-1001 in patients with advanced solid tumors
    Sausville, Edward A.
    Anthony, Stephen P.
    Garbo, Lawrence E.
    Shkolny, Dana
    Yurkovetskiy, Alex V.
    Bethune, Claudette
    Schwertschlag, Ullrich
    Fram, Robert J.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3383S - 3383S
  • [47] A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors
    Juric, Dejan
    Barve, Minal
    Vaishampayan, Ulka
    Roda, Desamparados
    Calvo, Aitana
    Janez, Noelia Martinez
    Trigo, Jose
    Greystoke, Alastair
    Harvey, R. Donald
    Olszanski, Anthony J.
    Opyrchal, Mateusz
    Spira, Alexander
    Thistlethwaite, Fiona
    Jimenez, Begona
    Sappal, Jessica Huck
    Kannan, Karuppiah
    Riley, Jason
    Li, Cheryl
    Li, Cong
    Gregory, Richard C.
    Miao, Harry
    Wang, Shining
    CANCER MEDICINE, 2024, 13 (05):
  • [48] Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors
    Tolcher, Anthony W.
    LoRusso, Patricia
    Arzt, Jennifer
    Busman, Todd A.
    Lian, Guinan
    Rudersdorf, Niki S.
    Vanderwal, Carol Ann
    Kirschbrown, Whitney
    Holen, Kyle D.
    Rosen, Lee S.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (05) : 1025 - 1032
  • [49] Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors
    Anthony W. Tolcher
    Patricia LoRusso
    Jennifer Arzt
    Todd A. Busman
    Guinan Lian
    Niki S. Rudersdorf
    Carol Ann Vanderwal
    Whitney Kirschbrown
    Kyle D. Holen
    Lee S. Rosen
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 1025 - 1032
  • [50] A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment
    Saif, Muhammad Wasif
    Becerra, Carlos R.
    Fakih, Marwan G.
    Sun, Weijing
    Popovic, Lazar
    Krishnamurthi, Smitha
    George, Thomas J.
    Rudek, Michelle A.
    Shepard, Dale R.
    Skopek, Jiri
    Sramek, Vladimir
    Zaric, Bojan
    Yamamiya, Ikuo
    Benhadji, Karim A.
    Hamada, Kensuke
    He, Yaohua
    Rosen, Lee
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (03) : 485 - 497
12345